BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35670897)

  • 21. Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients.
    Wong YJ; Zhaojin C; Tosetti G; Degasperi E; Sharma S; Agarwal S; Chuan L; Huak CY; Jia L; Xiaolong Q; Saraya A; Primignani M
    Clin Mol Hepatol; 2023 Jan; 29(1):135-145. PubMed ID: 36064306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
    Zhou H; Long J; Hu H; Tian CY; Lin SD
    World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosis.
    Asesio N; Pollo-Flores P; Caliez O; Munteanu M; Ngo A; Ngo Y; Poynard T; Thabut D; Rudler M
    Dig Liver Dis; 2022 May; 54(5):645-653. PubMed ID: 34583904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study.
    Han MAT; Vipani A; Noureddin N; Ramirez K; Gornbein J; Saouaf R; Baniesh N; Cummings-John O; Okubote T; Setiawan VW; Rotman Y; Loomba R; Alkhouri N; Noureddin M
    Liver Int; 2020 Sep; 40(9):2242-2251. PubMed ID: 32652744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria.
    Jindal A; Sharma S; Agarwal S; Kumar M; Saraya A; Sarin SK
    Hepatol Int; 2022 Feb; 16(1):89-98. PubMed ID: 35072932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of different Baveno criteria to detect esophageal varices irrespective of their size in patients with compensated cirrhosis.
    Ahmed S; Sharma S; Agarwal S; Wong YJ; Putera M; Saraya A
    Indian J Gastroenterol; 2023 Oct; ():. PubMed ID: 37840111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extending and validating the Baveno VI criteria for the exclusion of high-risk varices.
    Barbulescu A; Ratiu I; Sporea I; Lungeanu D; Lupusoru R; Miutescu B; Danila M; Popescu A; Sirli R
    Med Ultrason; 2021 Aug; 23(3):265-270. PubMed ID: 33657192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
    Semmler G; Alonso López S; Pons M; Lens S; Dajti E; Griemsmann M; Zanetto A; Burghart L; Hametner-Schreil S; Hartl L; Manzano M; Rodriguez-Tajes S; Zanaga P; Schwarz M; Gutierrez ML; Jachs M; Pocurull A; Polo B; Ecker D; Mateos B; Izquierdo S; Real Y; Ahumada A; Bauer DJM; Mauz JB; Casanova-Cabral M; Gschwantler M; Russo FP; Azzaroli F; Maasoumy B; Reiberger T; Forns X; Genesca J; Bañares R; Mandorfer M;
    J Hepatol; 2024 Jul; 81(1):76-83. PubMed ID: 38521170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
    Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Saraya A
    Am J Gastroenterol; 2020 Oct; 115(10):1650-1656. PubMed ID: 32516202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Dajti E; Ravaioli F; Marasco G; Alemanni LV; Colecchia L; Ferrarese A; Cusumano C; Gemini S; Vestito A; Renzulli M; Golfieri R; Festi D; Colecchia A
    Am J Gastroenterol; 2022 Nov; 117(11):1825-1833. PubMed ID: 35973171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving portal hypertension through Baveno VII recommendations.
    Mendizabal M; Cançado GGL; Albillos A
    Ann Hepatol; 2024; 29(1):101180. PubMed ID: 37984701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHESS-ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: An international multicenter study.
    Wong YJ; Li J; Liu C; Chen Z; Chan YH; Putera M; Teh KB; Ang TL; Zhao L; Yan Z; Kumar R; Li X; Qi X
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1043-1051. PubMed ID: 35253271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of High-Risk Varices in Patients with Compensated Advanced Chronic Liver Disease in Saudi Arabia.
    Ismail M
    Clin Exp Gastroenterol; 2023; 16():117-127. PubMed ID: 37489180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.
    Lee HA; Kim SU; Seo YS; Lee YS; Kang SH; Jung YK; Kim MY; Kim JH; Kim SG; Suk KT; Jung SW; Jang JY; An H; Yim HJ; Um SH
    Liver Int; 2019 Jun; 39(6):1071-1079. PubMed ID: 30589490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.
    Mózes FE; Lee JA; Selvaraj EA; Jayaswal ANA; Trauner M; Boursier J; Fournier C; Staufer K; Stauber RE; Bugianesi E; Younes R; Gaia S; Lupșor-Platon M; Petta S; Shima T; Okanoue T; Mahadeva S; Chan WK; Eddowes PJ; Hirschfield GM; Newsome PN; Wong VW; de Ledinghen V; Fan J; Shen F; Cobbold JF; Sumida Y; Okajima A; Schattenberg JM; Labenz C; Kim W; Lee MS; Wiegand J; Karlas T; Yılmaz Y; Aithal GP; Palaniyappan N; Cassinotto C; Aggarwal S; Garg H; Ooi GJ; Nakajima A; Yoneda M; Ziol M; Barget N; Geier A; Tuthill T; Brosnan MJ; Anstee QM; Neubauer S; Harrison SA; Bossuyt PM; Pavlides M;
    Gut; 2022 May; 71(5):1006-1019. PubMed ID: 34001645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
    Jindal A; Agarwal S; Sharma S; Kumar M; Saraya A; Sarin SK
    Dig Dis Sci; 2023 May; 68(5):2149-2157. PubMed ID: 36562888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of Spleen Shear Wave Elastography for the Screening of High-risk Varices in Patients with Compensated Advanced Chronic Liver Disease.
    Joseph RC; Devadas K; Varghese J; Oommen TT; Hareendran A; Nahaz N; Narayanan V; George B
    J Assoc Physicians India; 2022 Nov; 70(11):11-12. PubMed ID: 37355947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness.
    Chow JC; Wong GL; Chan AW; Shu SS; Chan CK; Leung JK; Choi PC; Chim AM; Chan HL; Wong VW
    J Gastroenterol Hepatol; 2019 Jan; 34(1):241-248. PubMed ID: 29890010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Moctezuma-Velazquez C; Saffioti F; Tasayco-Huaman S; Casu S; Mason A; Roccarina D; Vargas V; Nilsson JE; Tsochatzis E; Augustin S; Montano-Loza AJ; Berzigotti A; Thorburn D; Genesca J; Abraldes JG
    Am J Gastroenterol; 2019 Mar; 114(3):446-452. PubMed ID: 30315285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. THE ROLE OF ELASTOGRAPHY IN CLINICALLY SIGNIFICANT PORTAL HYPERTENSION.
    Mattos AA; Mattos AZ; Sartori GDP; Both GT; Tovo CV
    Arq Gastroenterol; 2023; 60(4):525-535. PubMed ID: 38018555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.